EIF3D interacts with GRP78 to prevent protein degradation, activating the unfolded protein response and inducing resistance to therapy, underscoring the importance of understanding molecular mechanisms of metabolic reprogramming in RCC to develop more effective treatments [129]. Here, EIF3D is linked to renal cell carcinoma.